Press Releases
WASHINGTON—ZERO Prostate Cancer (ZERO) presented U.S. Senator John Boozman (R-AR) with its 2026 Prostate Cancer Champion Award for his leadership advancing policies that prioritize enhanced care and research.
“As someone whose family has experience with this disease, I am proud to advocate on behalf of those facing prostate cancer and their loved ones. We are working to increase bipartisan support for expanding insurance coverage for prostate cancer screenings in addition to advancing additional funding for research and awareness efforts. It is an honor to be recognized for this life-saving work and I look forward to making more progress on delivering timely hope and help,” Boozman said.
“Sen. John Boozman's leadership on the PSA Screening for High-risk Insured Men (HIM) Act and his efforts to expand care for veterans living with prostate cancer will save lives,” said CEO of ZERO Prostate Cancer Courtney Bugler. “We are proud to recognize his advocacy with the 2026 Prostate Cancer Champion Award and look forward to continuing to work with him to advance prostate cancer awareness, early detection, and improved outcomes for all men.”
This Congress, Boozman and Senator Cory Booker (D-NJ) introduced the Prostate-Specific Antigen (PSA) Screening for High-risk Insured Men (HIM) Act that would require private health insurance plans to cover preventive prostate cancer screenings without imposing any cost-sharing requirements for men with an elevated risk of developing prostate cancer.
The senator also championed increased funding for the National Cancer Institute in Fiscal Year 2026 appropriations.
Prostate cancer affects 1 in 8 American men in their lifetime and disproportionately affects African American men, with 1 in 6 being diagnosed. Individuals who have at least one close family member diagnosed with the disease are at least twice as likely to be diagnosed themselves.
Currently, the Prostate-Specific Antigen test is the most effective tool for detection. When detected in early stage, prostate cancer is almost 100 percent survivable.